Michael Aaron Kelly is Director of HOOKIPA Pharma Inc.. Currently has a direct ownership of 5,754 shares of HOOK, which is worth approximately $17,262. The most recent transaction as insider was on Oct 21, 2020, when has been sold 5,754 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.75K
0% 3M change
0% 12M change
Total Value Held $17,262

Michael Aaron Kelly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 21 2020
BUY
Grant, award, or other acquisition
-
5,754 Added 50.0%
5,754 Common Stock

Also insider at

FOLD
AMICUS THERAPEUTICS, INC. Healthcare
NEO
NEOGENOMICS INC Healthcare
BOOM
DMC Global Inc. Energy
APRE
Aprea Therapeutics, Inc. Healthcare
PRME
Prime Medicine, Inc.
MAK

Michael Aaron Kelly

Director
Philadelphia, PA

Track Institutional and Insider Activities on HOOK

Follow HOOKIPA Pharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HOOK shares.

Notify only if

Insider Trading

Get notified when an Hookipa Pharma Inc. insider buys or sells HOOK shares.

Notify only if

News

Receive news related to HOOKIPA Pharma Inc.

Track Activities on HOOK